Artificial Intelligence

A novel gene therapy aims to cross the blood-brain barrier, offering new hope for Tuberous Sclerosis Complex, thanks to a powerful new partnership.

The Grammy-winning bassist and vocalist brings a unique, intimate quartet experience to the W Hollywood for an exclusive, one-night performance.

A new biotech emerges with a promising, late-stage gene therapy for Sanfilippo syndrome, offering a potential lifeline for children with no other options.

A breakthrough study validates a low-cost blood test that can detect multiple cancers and liver diseases, poised to transform preventative healthcare.

With profits up and a new CEO, TVA is pouring billions into new generation, betting on advanced nuclear power to meet soaring demand from data centers.

Shopify crushes Q1 with 34% revenue growth and $100B in merchant sales, yet its stock falters on a cautious outlook. Is its AI bet enough to win investors?

Despite economic gloom, shoppers are spending confidently, armed with digital deals and AI. A new study reveals how this shift is rewriting the rules for retail.

Broker-dealer AmerX launches an equity research division, integrating its NYSE floor presence with a new focus on physical AI to deliver actionable insights.

The utility giant posted strong first-quarter earnings, driven by surging industrial demand, and reaffirmed its outlook amid a historic investment plan.

A $20M investment in Seedli Capital signals growing institutional belief in tokenized real-world assets. But can the Web3 world meet TradFi's demands?

A new report reveals U.S. firms lead in security spending intent but lag in AI deployment, creating a dangerous gap between belief and reality.

Dubai-based Surexo surpasses 500,000 users, leveraging AI and a security-first approach to expand its fintech footprint across 30+ countries.

New research reveals CFO salaries are surging toward $4M, yet tenures are plummeting. A look at the high-risk, high-reward world of modern finance chiefs.

A new 'dream team' of experts will guide AI development to create non-invasive tools for a deadly lung disease, aiming to replace painful procedures.

With new backing from Catchment Capital and Stellus, Phoenix-based Vertech is poised to expand its critical role in automating America's industries.

As enterprises deploy advanced AI, a new security market is set to explode from zero to $8B by 2030, forcing a rethink of how we protect intelligent systems.

UK biotech Cytospire Therapeutics secures major funding to push its safer, more selective gamma delta T-cell engager into clinical trials for solid tumors.

The new Spring 2026 platform moves beyond data storage, using AI to transform MedTech regulatory affairs into a strategic, high-speed execution engine.

Global agency IDX opens a Swiss office, a strategic move fueled by rising client demand for evidence-based, AI-powered marketing and PR strategies.

UK biotech Cytospire secures a major Series A to bring its novel pan-gamma delta T cell engagers, targeting tough solid tumors, into clinical trials.